Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19
Globe Newswire23-11-2023, 08:08
The Shyft Group to Present at the Raymond James 44th Annual 3-03-2023, 19:39